Ars Pharmaceuticals Inc (SPRY)
EBITDA Margin
-177.04%
TTM · Period ending:
SPRY EBITDA Margin
Latest reported-177.04%period ending
Latest reported-177.04%period ending
SPRY EBITDA Margin (0.00% → -177.04%)
Annual ebitda margin
High-resolution chart · PNG
SPRY ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -198.6426% | |
| 9.3832% | |
| -180,973.3333% | |
| -2,611.1702% | |
| -361.8598% | |
| -2.596% | |
| 0% | |
| 0% |